הלוואות ואשראי לטווח ארוך של החברה: galmedpharma.com (GLMD)

This daily price chart for Galmed Pharmaceuticals (GLMD) on the GURU.Markets platform reflects the asset's dynamics, with a current value of 0.00. Galmed Pharmaceuticals creates unique treatments for NASH that target inflammatory processes, establishing the company as a segment favorite. The production cycle relies on sterile laboratories and experienced synthesis lines. Looking ahead, FDA approval is expected to drive massive revenue growth due to low production costs and formula exclusivity.

The specifics of liver disease drug development at Galmed Pharmaceuticals (GLMD) make monitoring the issuer's long-term liabilities critical for assessing financial stability. This indicator aggregates all accounts payable with a maturity of more than one year. It measures the volume of borrowed capital that the company is obligated to repay over the long term. An increase in this metric, coupled with a dependence on investments, signals a risk of default. Minimizing debt provides protection against liquidity gaps.